Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder
This study has been completed.
Study NCT00061802
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: June 4, 2003
Last Updated: December 1, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
